Miguel Quijada‐Álamo

Statistics

Publications

Citations

357

H-Index

Active since

2017

Affiliations

Instituto de Investigación Biomédica de Salamanca(Current)

Centro de Investigación del Cáncer

Universidad de Salamanca

Hospital Universitario Infanta Leonor

Dana-Farber Cancer Institute

Miguel Quijada‐Álamo is an author at Instituto de Investigación Biomédica de Salamanca specializing in cancer genetics, molecular oncology, and medicine.

ORCID

Publications per year

2017–2025

Publications

Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia

Maribel Forero‐Castro, Cristina Robledo, Rocío Benito et al. · British Journal of Cancer · 2017 · 51 citations · Full text

Medicine, Genetics, Hematology +17

Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia

Miguel Quijada‐Álamo, María Hernández‐Sánchez, Cristina Robledo et al. · Journal of Hematology & Oncology · 2017 · 49 citations · Full text

Life Sciences, Genetics, Hematology +17

Cholesterol mobilization regulates dendritic cell maturation and the immunogenic response to cancer

Meriem Belabed, Matthew D. Park, Cédric M. Blouin et al. · Nature Immunology · 2025 · 43 citations

Life Sciences, Cell Biology, Immunology +16

The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of <i>BCR/ABL in vitro</i> and in a xenograft model of chronic myeloid leukemia

Ignacio García‐Tuñón, María Hernández‐Sánchez, José Luis Ordóñez et al. · Oncotarget · 2017 · 40 citations · Full text

Medicine, Cancer Biology, Molecular Genetics +17

CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition

Miguel Quijada‐Álamo, María Hernández‐Sánchez, Verónica Alonso-Pérez et al. · Leukemia · 2020 · 37 citations · Full text

Medicine, Genetics, Oncology +16

1–5 of 12